Functional Approach for Coronary Artery Disease: Filling the Gap Between Evidence and Practice

Joo Myung Lee1, Joon Hyung Doh2, Chang Wook Nam3

  • 1Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Insights

Fractional flow reserve (FFR) and instantaneous wave free ratio (iFR) guide coronary artery disease treatment. This review explores unresolved questions regarding these pressure wire assessments and microvascular dysfunction in patient prognosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Physiology

Background:

  • Myocardial ischemia is a key prognostic factor in coronary artery disease (CAD).
  • Ischemia-guided revascularization is a standard of care for CAD patients.
  • Pressure wire assessment, including Fractional Flow Reserve (FFR), guides revascularization decisions.

Purpose of the Study:

  • To review recent studies addressing unresolved issues in pressure wire assessment for CAD.
  • To explore the mechanisms of discordance between resting and hyperemic indices.
  • To evaluate the role of physiologic indices and microvascular dysfunction in patient prognosis.

Main Methods:

  • Review of recent clinical studies and trials.
  • Analysis of data comparing FFR and instantaneous wave free ratio (iFR).
  • Investigation into the impact of discordant physiologic index results and microvascular dysfunction.

Main Results:

  • FFR-guided revascularization is superior to angiography-guided strategy.
  • The hyperemia-free index, iFR, demonstrated non-inferiority to FFR in clinical outcomes.
  • Several unresolved issues remain, including index discordance and microvascular dysfunction's role.

Conclusions:

  • Pressure wire assessment provides valuable guidance for revascularization in CAD.
  • Further research is needed to address discordance between indices and the prognostic role of microvascular dysfunction.
  • Optimizing the use of physiologic indices beyond per-vessel decisions is crucial for improving patient outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
The Evidence for Evolution02:55

The Evidence for Evolution

Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.4K